Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors and Clomipramine in Pediatric Obsessive-Compulsive Disorder.
We conducted a meta-analysis to examine the following: the time course of response to selective serotonin reuptake inhibitors (SSRIs) and clomipramine in pediatric obsessive-compulsive disorder (OCD); whether higher doses of SSRIs are associated with an improved response in pediatric OCD; differences in efficacy among SSRI agents; differences in efficacy between SSRIs and clomipramine; and whether the time course and magnitude of response to SSRIs are different in pediatric and adult patients with OCD.



We searched PubMed and CENTRAL for randomized controlled trials comparing SSRIs (or clomipramine) to placebo for the treatment of pediatric OCD and using the Children's Yale-Brown Obsessive-Compulsive Scale as an outcome. We extracted weekly symptom data from trials to characterize the trajectory of pharmacological response to SSRIs. Pooled estimates of treatment effect were calculated based on weighted mean differences between the treatment and placebo groups.



Nine trials involving 801 children with OCD were included in this meta-analysis. A logarithmic model indicating that the greatest benefits occurred early in treatment best fit the longitudinal data for both clomipramine and SSRIs. Clomipramine was associated with a greater measured benefit compared to placebo than SSRIs. There was no evidence for a relationship between SSRI dosing and treatment effect, although data were limited. Adults and children with OCD demonstrated a similar degree and time course of response to SSRIs in OCD.



These results suggest that the greatest incremental treatment gains in pediatric OCD occur early in SSRI treatment (similar to adults with OCD and children and adults with major depression).
University of Vermont Medical Center, Burlington.
Anjali L
AL
Varigonda
Yale Child Study Center, New Haven, CT.
Ewgeni
E
Jakubovski
Yale Child Study Center and Yale University. Electronic address: michael.bloch@yale.edu.
Michael H
MH
Bloch
D002648:Child; D002997:Clomipramine / Q000627:therapeutic use*; D006801:Humans; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy* / Q000523:psychology; D016032:Randomized Controlled Trials as Topic; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D016896:Treatment Outcome
D002997:Clomipramine; D017367:Selective Serotonin Reuptake Inhibitors
clomipramine; meta-analysis; obsessive-compulsive disorder; selective serotonin reuptake inhibitors
J Am Acad Child Adolesc Psychiatry. 2001 Feb;40(2):222-9
11211371
J Clin Psychiatry. 2016 May;77(5):e605-11
27249090
Arch Gen Psychiatry. 1987 Jan;44(1):81-9
3541830
Mol Psychiatry. 2010 Aug;15(8):850-5
19468281
J Am Acad Child Adolesc Psychiatry. 2002 Dec;41(12):1431-8
12447029
J Am Acad Child Adolesc Psychiatry. 1991 May;30(3):495-8
2055889
J Am Acad Child Adolesc Psychiatry. 1992 Nov;31(6):1062-9
1429406
BMJ. 1995 Aug 26;311(7004):551-3
7663213
Br J Psychiatry. 1999 Apr;174:297-303
10533547
J Am Acad Child Adolesc Psychiatry. 2001 Jul;40(7):773-9
11437015
Am J Psychiatry. 2007 Jul;164(7 Suppl):5-53
17849776
Arch Gen Psychiatry. 1989 Nov;46(11):1012-6
2510699
Br J Psychiatry. 1995 Apr;166(4):424-43
7795913
J Consult Clin Psychol. 1997 Feb;65(1):44-52
9103733
J Clin Psychopharmacol. 2002 Jun;22(3):309-17
12006902
JAMA. 1998 Nov 25;280(20):1752-6
9842950
Cochrane Database Syst Rev. 2008 Jan 23;(1):CD001765
18253995
Psychopharmacology (Berl). 1998 Apr;136(3):205-16
9566805
J Am Acad Child Adolesc Psychiatry. 2001 Oct;40(10):1175-81
11589530
J Behav Ther Exp Psychiatry. 1993 Jun;24(2):149-53
8263222
J Psychiatr Res. 2013 Nov;47(11):1700-7
23948637
J Child Adolesc Psychopharmacol. 2003;13 Suppl 1:S19-29
12880497
Arch Gen Psychiatry. 1989 Nov;46(11):1006-11
2684084
Mol Psychiatry. 2006 Jul;11(7):622-32
16585942
Arch Gen Psychiatry. 2006 Nov;63(11):1217-23
17088502
J Child Psychol Psychiatry. 2005 Jul;46(7):735-54
15972068
J Am Acad Child Psychiatry. 1979 Autumn;18(4):616-27
541469
J Am Acad Child Adolesc Psychiatry. 2015 Apr;54(4):251-62
25791142
J Child Adolesc Psychopharmacol. 1990 Fall;1(2):133-40
19630661
Int Clin Psychopharmacol. 1995 Mar;10(1):11-8
7622800
J Am Acad Child Adolesc Psychiatry. 2012 Jan;51(1):98-113
22176943
J Am Acad Child Adolesc Psychiatry. 2004 Nov;43(11):1387-96
15502598
J Am Acad Child Adolesc Psychiatry. 2011 Jan;50(1):63-72
21156271
J Am Acad Child Adolesc Psychiatry. 2015 Jul;54(7):557-64
26088660
JAMA. 2004 Oct 27;292(16):1969-76
15507582
Am J Psychiatry. 2003 Nov;160(11):1919-28
14594734
J Am Acad Child Adolesc Psychiatry. 1997 Jun;36(6):844-52
9183141
Psychopharmacol Bull. 1996;32(1):157-65
8927667
Arch Gen Psychiatry. 1995 Jan;52(1):53-60
7811162
J Am Acad Child Adolesc Psychiatry. 1992 Jan;31(1):45-9
1537780